Circulating antibodies to guanosine in systemic lupus erythematosus: correlation with nephritis and polyserositis by acute and longitudinal analyses
| Autor: | K K, Colburn, L M, Green, A K, Wong, A L, Wong |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Adult
Male Adolescent Anti-nuclear antibody Lupus nephritis Arthritis Guanosine Enzyme-Linked Immunosorbent Assay 030204 cardiovascular system & hematology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Rheumatology immune system diseases medicine Humans Pericarditis Longitudinal Studies skin and connective tissue diseases Pleurisy Aged Serositis 030203 arthritis & rheumatology biology business.industry Autoantibody Middle Aged medicine.disease Lupus Nephritis chemistry Antibodies Antinuclear Acute Disease Immunology biology.protein Female Antibody business Nephritis Anti-SSA/Ro autoantibodies |
| Zdroj: | Lupus. 10:410-417 |
| ISSN: | 1477-0962 0961-2033 |
| DOI: | 10.1191/096120301678646155 |
| Popis: | Systemic lupus erythematosus (SLE) is characterized by autoantibodies, including antibodies to the nucleosides of DNA. Guanosine is the most immunogenic nucleoside. In this study serum antiguanosine antibody levels were compared with disease activity, determined by their SLEDI score, in 86 patients with SLE. Sera from these patients were tested, by ELISA, for autoantibodies to guanosine, single-stranded DNA (ssDNA), and double-stranded DNA (dsDNA). Anti-doublestranded DNA levels were also measured by RIA. Resultant values from these assays were correlated with SLE disease activity, and compared with specific features of SLE. The strongest correlation was higher levels of antiguanosine antibodies in patients with active lupus nephritis and polyserositis compared to patients with inactive disease (P < 0.0001). Antiguanosine levels also correlated with arthritis (P < 0.006), CNS lupus (P < 0.005), and hematologic manifestations of SLE (P < 0.002). To test the validity of this association in chronic SLE, serum antiguanosine antibodies were measured in patients with SLE at various phases of disease activity. Twelve patients with SLE had serum samples drawn at active, active-improved, and inactive phases over a 3–7 y period. Differences were significant for serum antiguanosine antibodies in the active group compared to the inactive group (P < 0.05) and the active vs the active-improved group (P < 0.02), unlike those for dsDNA and ssDNA by ELISA or RIA. Antiguanosine antibodies correlated more closely with disease activity in SLE patients in this longitudinal study than either anti-dsDNA or ssDNA antibodies. Thus, antibodies to guanosine correlated as well or better with disease activity than the other anti-DNA antibodies measured and should be considered to contribute to the pathology of SLE, especially lupus nephritis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|